Pages that link to "Q48270253"
Jump to navigation
Jump to search
The following pages link to The quaternary lidocaine derivative, QX-314, exerts biphasic effects on transient receptor potential vanilloid subtype 1 channels in vitro (Q48270253):
Displaying 10 items.
- The quaternary lidocaine derivative QX-314 produces long-lasting intravenous regional anesthesia in rats (Q33763447) (← links)
- Permeation and block of TRPV1 channels by the cationic lidocaine derivative QX-314 (Q36770939) (← links)
- Targeting Pain-evoking Transient Receptor Potential Channels for the Treatment of Pain (Q37362053) (← links)
- Evaluation of the cardiotoxicity and resuscitation of rats of a newly developed mixture of a QX-314 analog and levobupivacaine (Q37733193) (← links)
- Recent Developments Regarding Voltage-Gated Sodium Channel Blockers for the Treatment of Inherited and Acquired Neuropathic Pain Syndromes (Q37946885) (← links)
- Neurological perspectives on voltage-gated sodium channels. (Q38042001) (← links)
- Subunit and frequency-dependent inhibition of acid sensing ion channels by local anesthetic tetracaine (Q41506329) (← links)
- Expression-dependent pharmacology of transient receptor potential vanilloid subtype 1 channels in Xenopus laevis oocytes (Q41566415) (← links)
- The Preclinical Pharmacological Study of a Novel Long-Acting Local Anesthetic, a Fixed-Dose Combination of QX-OH/Levobupivacaine, in Rats (Q93046959) (← links)
- Clinical Efficacy of Ultrasound-Mediated Transdermal Lidocaine and Capsaicin Delivery for the Treatment of Allodynia Caused by Herpes Zoster (Q96306883) (← links)